Results 221 to 230 of about 98,699 (349)
Characterisation of sleep apneas and respiratory circuitry in mice lacking CDKL5
Summary CDKL5 deficiency disorder is a rare genetic disease caused by mutations in the CDKL5 gene. Central apneas during wakefulness have been reported in patients with CDKL5 deficiency disorder. Studies on CDKL5‐knockout mice, a CDKL5 deficiency disorder model, reported sleep apneas, but it is still unclear whether these events are central (central ...
Gabriele Matteoli +12 more
wiley +1 more source
Obstructive sleep apnea syndrome: aeronautical medical assessment. [PDF]
Vale JS, Pimenta SM.
europepmc +1 more source
Summary Sleep‐disordered breathing (SDB) is linked to cognitive dysfunction. Although SDB is common in stroke patients, the impact of SDB and its early treatment on cognitive functioning after stroke remains poorly investigated. Therefore, we explored the association between SDB and post‐stroke cognitive functioning, including the impact of early SDB ...
Irina Filchenko +9 more
wiley +1 more source
Lamina cribrosa curvature index as a biomarker of non-glaucomatous optic neuropathy in obstructive sleep apnea syndrome. [PDF]
Ermis S +6 more
europepmc +1 more source
Decrease of excessive daytime sleepiness after shunt treatment for normal pressure hydrocephalus
Summary Sleepiness and apathy are often reported in patients with normal pressure hydrocephalus. However, research on outcomes after shunt surgery has mainly focused on the classical triad symptoms, that is, gait, cognition, and bladder dysfunction. This study aimed to describe the effects of shunt treatment on excessive daytime sleepiness and whether ...
Simon Lidén +4 more
wiley +1 more source
The Correlation Study of Bone Metabolism and Inflammatory Markers with Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea Syndrome. [PDF]
Guo G +5 more
europepmc +1 more source
Blood Pressure “Dipping” and “Non-Dipping” in Obstructive Sleep Apnea Syndrome Patients [PDF]
Mayumi Suzuki +3 more
openalex +1 more source
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng +3 more
wiley +1 more source
Three Decades of Managing Pediatric Obstructive Sleep Apnea Syndrome: What's Old, What's New. [PDF]
Panetti B +8 more
europepmc +1 more source

